Cerebral vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Online mental health platform for therapy, medication management, and psychiatry, San Francisco CA, raised $300M+. Serves anxiety, depression, ADHD, and insomnia.
About
Cerebral is a San Francisco, California-based online mental health company founded in 2020 that offers therapy, psychiatric evaluations, and medication management through a telehealth platform. The company raised over $300 million, achieving unicorn status in 2021 during a period of rapid growth, and serves patients with conditions including anxiety, depression, ADHD, insomnia, and bipolar disorder through a subscription-based access model.\n\nCerebral's model is designed to make psychiatric care and therapy more accessible than traditional in-person services by offering online intake, same-week appointments with licensed clinicians, electronic prescriptions, and medication delivery through pharmacy partners. The platform serves both self-pay and insurance-covered patients, having expanded insurance contracting significantly to reduce cost barriers. Cerebral employs a large clinician workforce of therapists and psychiatric nurse practitioners operating across most US states.\n\nThe company navigated a period of regulatory and reputational scrutiny in 2022–2023 related to prescribing practices and marketing claims, which led to leadership changes, workforce restructuring, and a strategic refocus on clinical quality and compliance. Cerebral has since invested in clinical governance infrastructure, stricter prescribing protocols, and transparent outcomes reporting. The company continues to compete with Talkspace, Done, and Done Global in the online psychiatry and therapy market, and has repositioned around a more clinically rigorous, insurance-first approach following the operational challenges of its hypergrowth phase.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.